Inceptor Bio, LLC

Venture capital mega-rounds of $100m or more drove the overall increase in VC funding raised by biopharmaceutical companies in 2024, as Evaluate data recently revealed , and as the National Venture C

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kaken Obtains Aadi’s Fyarro, Comm

Amylyx Hopes Sunnybrook Might Discover New Methods For Fighting ALS Although it is in the midst of a protracted effort to obtain US Food and Drug Administration approval for its investigational mitoch

The global non-profit Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), which provides funding and other support for early-stage development of treatments, diagnostics an